Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients.
about
Hepatocellular carcinoma and the risk of occupational exposureEndozepine-4 levels are increased in hepatic comaHepatitis C virus infection and nonalcoholic steatohepatitisEffects of rosuvastatin and/or β-carotene on non-alcoholic fatty liver in ratsThe immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance.Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.Anorectal mucosal melanoma.D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis
P2860
Q26750646-42A8AEFF-316F-4B93-B201-636AEB18C334Q35942406-BBF0151D-C8F3-4E09-9DEC-B4881BD08FF1Q36179898-482B5DE5-F476-4B40-A680-402ECF1630C3Q36216714-E84A0C39-B2F3-4BCD-BDD9-44548B1D1BB8Q39535683-C1B8F250-ABE7-4719-9AB6-AFB8A0DB3FCAQ40078355-00D2EE2F-86B7-48B1-9F01-3665BFC45346Q41426862-DB2675F8-258E-4100-844D-065C61F1D27EQ52680468-6D1907ED-27A9-412C-A0C3-0D902BEBCE77Q57484445-3B4E7207-97BB-464D-8F3E-3C5016EE8CEA
P2860
Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rosuvastatin reduces nonalcoho ...... reduces NAFLD in HCV patients.
@ast
Rosuvastatin reduces nonalcoho ...... reduces NAFLD in HCV patients.
@en
type
label
Rosuvastatin reduces nonalcoho ...... reduces NAFLD in HCV patients.
@ast
Rosuvastatin reduces nonalcoho ...... reduces NAFLD in HCV patients.
@en
prefLabel
Rosuvastatin reduces nonalcoho ...... reduces NAFLD in HCV patients.
@ast
Rosuvastatin reduces nonalcoho ...... reduces NAFLD in HCV patients.
@en
P2093
P2860
P1433
P1476
Rosuvastatin reduces nonalcoho ...... reduces NAFLD in HCV patients
@en
P2093
Cristina Russo
Fabio Galvano
Gaetano Bertino
Giovanni Li Volti
Marco Vacante
Maria Giordano
Maria Pia Gargante
Mariano Malaguarnera
Michele Malaguarnera
P2860
P407
P50
P577
2011-02-01T00:00:00Z